SAB Biotherapeutics, Inc. (SABS): 8-K filed May 4, 2026

Form type
8-K
Filing date
May 4, 2026
Accession number
0001193125-26-204125
Filer
SAB Biotherapeutics, Inc. (CIK 1833214)